EMBO Molecular Medicine 
is dedicated to a new research discipline at the interface between clinical research and basic biology and publishes high quality research with immediate open access.
The concepts and approaches of molecular biology can lead to a deeper understanding of the molecular basis of disease states. Effective translation of resulting new insights into cells and their interactions in the human body could yield novel applications for the prevention, treatment and cure of human disease.
EMBO Molecular Medicine offers clinicians and researchers in this area the opportunity to publish their best work in a broadly distributed and highly visible forum, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists.
Priority articles are those offering novel and relevant molecular insight into the cellular and systemic processes underlying defined human diseases. Studies based on model organisms also fall within the scope of the journal, provided that the results presented are evidently and directly relevant to human disease.
Readers will be interested in new perspectives for clinical application at the levels of diagnosis, prevention and therapy.
Areas within the scope include, but are not limited to:
- Aging
- Angiogenesis
- Cancer biology
- Differentiation and development
- Endocrinology/Metabolic disease
- Systems medicine
- Gene therapy
- Immunology and inflammation
- Infectious diseases
- Neurodegeneration, neurological diseases and myopathies
- Stem cells and regenerative medicine
- Vascular and cardiovascular biology
EMBO Molecular Medicine is published for EMBO by Wiley-Blackwell .
